KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Common Equity (2016 - 2026)

Encompass Health (EHC) has disclosed Common Equity for 18 consecutive years, with $3.3 billion as the latest value for Q1 2026.

  • For Q1 2026, Common Equity rose 14.82% year-over-year to $3.3 billion; the TTM value through Mar 2026 reached $3.3 billion, up 14.82%, while the annual FY2025 figure was $3.2 billion, 15.21% up from the prior year.
  • Common Equity hit $3.3 billion in Q1 2026 for Encompass Health, up from $3.2 billion in the prior quarter.
  • Across five years, Common Equity topped out at $3.3 billion in Q1 2026 and bottomed at $1.7 billion in Q3 2022.
  • Average Common Equity over 5 years is $2.5 billion, with a median of $2.4 billion recorded in 2022.
  • Year-over-year, Common Equity fell 24.37% in 2022 and then grew 25.6% in 2023.
  • Encompass Health's Common Equity stood at $1.8 billion in 2022, then rose by 23.48% to $2.3 billion in 2023, then increased by 23.83% to $2.8 billion in 2024, then grew by 15.21% to $3.2 billion in 2025, then increased by 2.83% to $3.3 billion in 2026.
  • According to Business Quant data, Common Equity over the past three periods came in at $3.3 billion, $3.2 billion, and $2.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.